English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/232372
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

HYPEROXIA AND PARP INHIBITION DIFFERENTIALLY MODULATE TRANSCRIPTION PROFILE AND INFLAMMATION IN AGGRESSIVE MELANOMA AND NON-TRANSFORMED LUNG EPITHELIAL CELLS

AuthorsHerrera Campos, Ana Belén; Fernández Cortés, Mónica; Delgado-Bellido, Daniel; Delgado, Daniel; López Jiménez, Laura María; Montuenga, Luis M.; Oliver, Francisco Javier; García-Díaz, Ángel
Issue Date10-Dec-2020
AbstractThe local conditions of tumor cell growth, known as the tumor microenvironment (TME), are characterized by low oxygen supply (hypoxia) caused by insufficient blood delivery. Hypoxia cancers have a strong invasive potential, metastasis, resistance to therapy and a poor clinical prognosis. The key regulator of adaptation to tumor hypoxia is hypoxia inducible factor 1-¿ (HIF-1¿). Despite its significance, the underlying transformations that cause this highly aggressive behaviour are poorly understood, specific pharmacological inhibition of HIF-1¿ activation in the tumor are not available. Our group has shown that PARP inhibitors can modulate HIF-1¿ levels and its activation. On the other hand, hyperoxia could be a treatment of medical interest to fight tumors that present with hypoxia; nevertheless, its use may involve clinically unacceptable lung damage. AIMS: In this study, we aim to demonstrate that the use of PARP inhibitors (1) will interfere with the adaptation of the tumor to the hypoxic microenvironment (which is recreated with the hypoxia-mimetic,CoCl2), in combination with the use with oxygen to induce hyperoxia and (2) will decrease the lung damage induced by reactive oxygen species. Therefore, the combined use of oxygen and PARP inhibitors in metastatic melanoma (expressing high levels of HIF-1) could delay metastasis and improve the efficacy of anti-tumor therapy.
URIhttp://hdl.handle.net/10261/232372
Appears in Collections:(IPBLN) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
829195.pdf1,5 MBUnknownView/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.